CMX-2043 Mechanisms of Action In Vitro

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Cardiovascular Pharmacology

• Publication date

  2016-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/FJC.0000000000000408PMID 27195653
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CMX-2043 Efficacy in a Rat Model of Cardiac Ischemia–Reperfusion Injury

  2016influential reference
• Lipoic acid analogs with enhanced pharmacological activity.

  2014influential reference
• Pre-clinical and Clinical Safety Studies of CMX-2043: A Cytoprotective Lipoic Acid Analogue for Ischaemia–Reperfusion Injury

  2014cited by this paper
• Targeting phosphatidylinositol 3-kinase-Akt through hepatocyte growth factor for cardioprotection.

  2013influential reference
• Myocardial ischemia-reperfusion injury: a neglected therapeutic target.

  2013cited by this paper
• Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation.

  2012cited by this paper
• New α-lipoic acid derivative, DHL-HisZn, ameliorates renal ischemia-reperfusion injury in rats.

  2012cited by this paper
• Lipoic acid - biological activity and therapeutic potential

  2011cited by this paper
• Alpha-lipoic acid protects against myocardial ischemia/reperfusion injury via multiple target effects.

  2011cited by this paper
• Lipoic acid protects against reperfusion injury in the early stages of cerebral ischemia.

  2011cited by this paper
• Correction for Interference by Test Samples in High-Throughput Assays

  2009cited by this paper
• Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue

  2009cited by this paper
• Cardioprotective Effects of Alpha-Lipoic Acid on Myocardial Reperfusion Injury: Suppression of Reactive Oxygen Species Generation and Activation of Mitogen-Activated Protein Kinase

  2009cited by this paper
• α‐LIPOIC ACID PROTECTS AGAINST RENAL ISCHAEMIA–REPERFUSION INJURY IN RATS

  2008cited by this paper
• Effects of α-lipoic acid on ischemia-reperfusion-induced renal dysfunction in rats

  2008cited by this paper
• Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K/Akt but not ERK pathway.

  2008cited by this paper
• Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness.

  2008cited by this paper
• Alpha-lipoic acid protects against renal ischaemia-reperfusion injury in rats.

  2008cited by this paper
• Effects of alpha-lipoic acid on ischemia-reperfusion-induced renal dysfunction in rats.

  2008cited by this paper
• Shp2 Negatively Regulates Growth in Cardiomyocytes by Controlling Focal Adhesion Kinase/Src and mTOR Pathways

  2008cited by this paper
• PI3K pathway alterations in cancer: variations on a theme

  2008cited by this paper
• Protective effects of ischemic preconditioning and application of lipoic acid prior to 90 min of hepatic ischemia in a rat model.

  2007cited by this paper
• IP3 receptors in cell survival and apoptosis: Ca2+ release and beyond

  2007cited by this paper
• Alpha-lipoic acid as a directly binding activator of the insulin receptor: protection from hepatocyte apoptosis.

  2007influential reference
• α-Lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway

  2007cited by this paper
• Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial.

  2007cited by this paper
• Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway.

  2007cited by this paper
• Alpha-Lipoic Acid Protects against Hepatic Ischemia-Reperfusion Injury in Rats

  2007cited by this paper
• Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection

  2007cited by this paper
• Effect of Glucose-Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial Infarction: The CREATEECLA Randomized Controlled Trial

  2006cited by this paper
• Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin.

  2006cited by this paper
• A Single Bolus of a Long-acting Erythropoietin Analogue Darbepoetin Alfa in Patients with Acute Myocardial Infarction: A Randomized Feasibility and Safety Study

  2006cited by this paper
• The role of thiols in liver ischemia-reperfusion injury.

  2006cited by this paper
• Epsilon protein kinase C as a potential therapeutic target for the ischemic heart.

  2006cited by this paper
• PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning.

  2006cited by this paper
• Long-term efficacy of edaravone in patients with acute myocardial infarction.

  2006cited by this paper
• Assay Development and Screening of a Serine/Threonine Kinase in an On-Chip Mode Using Caliper Nanofluidics Technology

  2006influential reference
• Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts

  2006cited by this paper
• A cell-based immunocytochemical assay for monitoring kinase signaling pathways and drug efficacy.

  2005cited by this paper
• Impact of a Single Intravenous Administration of Nicorandil Before Reperfusion in Patients With ST-Segment–Elevation Myocardial Infarction

  2005cited by this paper
• Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.

  2005cited by this paper
• Mitochondrial permeability transition pore as a target for cardioprotection in the human heart.

  2005cited by this paper
• Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo

  2005cited by this paper
• Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors.

  2005cited by this paper
• Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury.

  2005cited by this paper
• Effects of Glucagon-Like Peptide-1 in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction After Successful Reperfusion

  2004cited by this paper
• Myocardial Protection at a Crossroads: The Need for Translation Into Clinical Therapy

  2004cited by this paper
• Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation.

  2004cited by this paper
• Interaction between Src and a C-terminal Proline-rich Motif of Akt Is Required for Akt Activation*

  2003cited by this paper
• Effect of Allopurinol Pretreatment on Free Radical Generation after Primary Coronary Angioplasty for Acute Myocardial Infarction

  2003cited by this paper
• Alpha-lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway.

  2003cited by this paper
• Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells.

  2003cited by this paper
• The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion.

  2003cited by this paper
• α-Lipoic acid preconditioning reduces ischemia-reperfusion injury of the rat liver via the PI3-kinase/Akt pathway

  2003cited by this paper
• Structural biology of insulin and IGF1 receptors: implications for drug design

  2002cited by this paper
• R-α-Lipoic Acid Action on Cell Redox Status, the Insulin Receptor, and Glucose Uptake in 3T3-L1 Adipocytes

  2002cited by this paper
• Protective Effect Of α‐LIPOIC Acid Against Ischaemic Acute Renal Failure In Rats

  2002cited by this paper
• R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes.

  2002cited by this paper
• Akt: versatile mediator of cell survival and beyond.

  2002cited by this paper
• Akt Activation Preserves Cardiac Function and Prevents Injury After Transient Cardiac Ischemia In Vivo

  2001influential reference
• Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe.

  2001cited by this paper
• Molecular aspects of lipoic acid in the prevention of diabetes complications.

  2001cited by this paper
• Schisandrin B modulates the ischemia-reperfusion induced changes in non-enzymatic antioxidant levels in isolated-perfused rat hearts

  2001cited by this paper
• Lipoic acid reduces ischemia-reperfusion injury in animal models.

  2000cited by this paper
• Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart.

  2000influential reference
• (R)‐α‐Lipoic acid‐supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate

  1999cited by this paper
• Mechanism of protein kinase B activation by insulin/insulin-like growth factor-1 revealed by specific inhibitors of phosphoinositide 3-kinase--significance for diabetes and cancer.

  1999cited by this paper
• (R)-alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate.

  1999cited by this paper
• The pharmacology of the antioxidant lipoic acid.

  1997cited by this paper
• Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction.

  1994cited by this paper
• Oxygen-radical absorbance capacity assay for antioxidants.

  1993cited by this paper
• Free radicals and their involvement during long-term myocardial ischemia and reperfusion.

  1990cited by this paper

• Interaction of Asparagusic Acid, Asparaptines and Related Dithiolane Derivatives With Angiotensin‐Converting Enzyme‐2 (ACE‐2): A Molecular Docking Study

  2025cites this paper
• CMX-2043 Treatment Limits Neural Injury Pathophysiology and Promotes Neurological and Cognitive Recovery in a Pediatric Porcine Traumatic Brain Injury Model

  2025cites this paper
• Catalase Activity in the Brain Is Associated with Recovery from Brain Injury in a Piglet Model of Traumatic Brain Injury

  2025influential citation
• Programmed Cell Death: Complex Regulatory Networks in Cardiovascular Disease

  2021cites this paper
• SUPPORT-1 (Subjects Undergoing PCI and Perioperative Reperfusion Treatment): A Prospective, Randomized Trial of CMX-2043 in Patients Undergoing Elective Percutaneous Coronary Intervention.

  2020cites this paper
• Investigational drugs in phase II clinical trials for acute coronary syndromes

  2019cites this paper
• CMX-2043 Efficacy in a Rat Model of Cardiac Ischemia–Reperfusion Injury

  2016cites this paper